Emergency Department VisitRAUCISABLENCT07037719
Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE)
An observational study of Emergency Department Visit, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.
Trial summary
The augmented rehabilitation of emergency surgeries (ARES, RAUC in French) is a research program supported by Amiens-Picardy University Hospital and the University of Picardy Jules Verne. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Emergency Department Visit
- How many people
- 300,000 participants
- Where
- 1 siteFrance
- Study dates
- 17 Jan 2025to 17 Jan 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients attending CHU Amiens-Picardie Emergency Department (ED).
Who may be able to join
- Adults (age 17+), all ED patients
Who cannot join
- Patients who object to data use
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE): a Retrospective Monocentric Pilot Study on Big-data
The augmented rehabilitation of emergency surgeries (ARES, RAUC in French) is a research program supported by Amiens-Picardy University Hospital and the University of Picardy Jules Verne. The RAUC program aims to enhance by multiple levers (enhanced recovery programs, artificial intelligence, organizational optimization, connected devices) the management of patients operated for digestive emergency surgery. RAUCisable aims to optimize the inclusion of eligible patients in the RAUC-AMIENS study and improve predictive models for patient management.
- Conditions
- Emergency Department Visit
- Keywords
- Personalized medicine, augmented rehabilitation, artificial intelligence, emergency surgery, digestive surgery
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Patients attending CHU Amiens-Picardie Emergency Department | Adults (age 17+), all ED patients |
What is being measured
The primary outcome is the main question the study is designed to answer.
Area Under the ROC Curve
Area Under the ROC Curve (AUROC) for RAUC-AMIENS inclusion
Measured: 30 days
Secondary outcomes (3)
AUROC and Mean Absolute Error
AUROC and Mean Absolute Error for continuous prediction of post-surgery LOS.
Measured: 30 days
AUROC of unattended readmission
AUROC of unattended readmission
Measured: 30 days
mean absolute error for readmission prediction
mean absolute error for readmission prediction
Measured: 30 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Jun 2025
- Study start17 Jan 2025
- Primary completion17 Jan 2026 (estimated)
- Study completion17 Jan 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Emergency Department VisitStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire, AmiensThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 300,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire, Amiens
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Jean-Marc REGIMBEAU, MD, Principal investigator, CHU Amiens-Picardie
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07037719
- Sponsor's protocol ID
- PI2025_843_0015
- Acronym
- RAUCISABLE
- Status last verified
- Jun 2025
- First submitted
- 11 Jun 2025
- Last updated
- 25 Jun 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Arnaud E, Dequen G, Chive E, Lignier D, Gacquer W, Diouf M, Balcaen T, Ghazali DA, Regimbeau JM. Identification and prediction of patients eligible for augmented rehabilitation in emergency gastrointestinal surgery (RAUCisable): A protocol for a single-centre, retrospective, observational study. PLoS One. 2026 Jun 3;21(6):e0350113. doi: 10.1371/journal.pone.0350113. eCollection 2026.
PubMed 42234717
Study at a glance
From the registry record, last updated by the sponsor on 25 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE): a Retrospective Monocentric Pilot Study on Big-data
- ClinicalTrials.gov ID
- NCT07037719
- Acronym / sponsor ID
- RAUCISABLE / PI2025_843_0015
- Conditions
- Emergency Department Visit
- Keywords
- Personalized medicine, augmented rehabilitation, artificial intelligence, emergency surgery, digestive surgery
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 300,000 participants (estimated)
- Lead sponsor
- Centre Hospitalier Universitaire, AmiensUniversity, hospital or other
- Study start
- 17 Jan 2025 (actual)
- Primary completion
- 17 Jan 2026 (estimated)
- Study completion
- 17 Jan 2026 (estimated)
- First posted
- 25 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The augmented rehabilitation of emergency surgeries (ARES, RAUC in French) is a research program supported by Amiens-Picardy University Hospital and the University of Picardy Jules Verne. The RAUC program aims to enhance by multiple levers (enhanced recovery programs, artificial intelligence, organizational optimization, connected devices) the management of patients operated for digestive emergency surgery. RAUCisable aims to optimize the inclusion of eligible patients in the RAUC-AMIENS study and improve predictive models for patient management.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients attending CHU Amiens-Picardie Emergency Department | – | –Adults (age 17+), all ED patients |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients attending CHU Amiens-Picardie Emergency Department (ED).
Key inclusion criteria (1 listed)
- Adults (age 17+), all ED patients
Key exclusion criteria (1 listed)
- Patients who object to data use
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Area Under the ROC Curve
Time frame: 30 days
Area Under the ROC Curve (AUROC) for RAUC-AMIENS inclusion
3 secondary outcomes
AUROC and Mean Absolute Error
Time frame: 30 days
AUROC of unattended readmission
Time frame: 30 days
mean absolute error for readmission prediction
Time frame: 30 days
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Jun 2025.
- Derived from this study: PubMed 42234717Arnaud E, Dequen G, Chive E, Lignier D, Gacquer W, Diouf M, Balcaen T, Ghazali DA, Regimbeau JM. Identification and prediction of patients eligible for augmented rehabilitation in emergency gastrointestinal surgery (RAUCisable): A protocol for a single-centre, retrospective, observational study. PLoS One. 2026 Jun 3;21(6):e0350113. doi: 10.1371/journal.pone.0350113. eCollection 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Emergency Department Visit
Not yet recruiting
Development, Validation, and Clinical Trial of a Prediction Tool for High-Risk Emergency Department Revisits
Emergency Department, Revisit
Not yet recruitingPhase 4
Starting HIV Prevention Medicine (PrEP) During an Emergency Department Visit With a Peer Navigator
HIV Prevention, Pre-Exposure Prophylaxis (PrEP)
Not yet recruitingObservational study
Clinical Governance of Home Care and 30-Day Stability
Home Care Services, Quality of Health Care
Active, not recruiting
Impact of Vitamin C on opioïd Consumption After an Emergency Department Visit for Acute Musculoskeletal Pain
Pain, Acute
Not yet recruiting
Acute Hospital Care at Home for People Living With Dementia
Emergency Department Visit, Home Care Services
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Jean-Marc REGIMBEAU, MD principal investigator
CHU Amiens-Picardie
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Emergency Department Visit, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 25 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jean-Marc REGIMBEAU, MD (+33 3 22 08 80 00, regimbeau.jean-marc@chu-amiens.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Area Under the ROC Curve (time frame: 30 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07037719, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2025.